Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 13 Sep 2021  |  North America  |  Market Research

    Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

    Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

    This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of...

    $4,950.00
  2. 09 Sep 2021  |  North America  |  Market Research

    Global Medical Device Leasing Growth Opportunities

    Vendors' Integration of Support Services and Shift from Product-centric to Value-oriented Business Models will Improve ROI and Mar

    Globally, hospitals and health systems face financial pressure caused by high operating and administrative costs, declining revenue and reimbursement rates, and the increasing cost of both medical devices (due to technology advancements) and infrastructure. The COVID-19 pandemic has intensified this financial crisis as patient volumes dropped and n...

    $2,450.00
  3. 03 Sep 2021  |  North America  |  Market Research

    Global Renal Care Management Growth Opportunities

    Value-based Renal Care to be a Key Growth Area

    The global prevalence of CKD is estimated to be about 9% to 10%. Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and mental ill hea...

    $4,950.00
  4. 27 Aug 2021  |  North America  |  Market Research

    US and EU Upstream Bioprocessing Growth Opportunities

    Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing

    The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

    $4,950.00
  5. 24 Aug 2021  |  North America  |  Market Research

    US and EU Biotech Industry VC Investment Growth Opportunities

    Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

    With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

    $2,450.00
  6. 16 Aug 2021  |  North America  |  Market Research

    Global Drug Discovery and Early Development Outsourcing Growth Opportunities

    Growing Research and Development Pipelines of Emerging Biopharmaceutical and Niche Technology Providers Drive Competitive Intensity

    Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...

    $4,950.00
  7. 12 Aug 2021  |  North America  |  Frost Radar

    Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...

    $4,950.00
  8. 04 Aug 2021  |  North America  |  Market Research

    Growth Opportunities Arising due to the Use of Commercial AI Models in Radiology

    The Intensely Competitive Landscape Necessitates the Repositioning of Value Through the Acceptance of New Business Models

    As artificial intelligence (AI) solutions gain acceptance in the imaging fraternity and among senior leaders in the health systems space, competition has intensified and necessitated the creation of differentiation strategies for companies that want to improve their revenue and sustain growth. The rapid proliferation of medical imaging AI companies...

    $2,450.00
  9. 03 Aug 2021  |  North America  |  Frost Radar

    Frost Radar™: Next-generation Surgical Robotic Technology Platforms, 2021

    A Benchmarking System to Spark Companies to Action – Innovation That Fuels New Deal Flow and Growth Pipelines

    During the last decade, adoption of robot-assisted surgery has increased significantly as opportunities have multiplied for performing minimally invasive procedures. Overall, surgical robotic platforms facilitate more precise surgeries and improve the repeatability of procedural movements. These benefits support faster recovery and better outcomes ...

    $4,950.00
  10. 23 Jul 2021  |  North America  |  Market Research

    US Digital Therapeutics Growth Opportunities

    Transformational Growth in New Business Models After COVID-19

    Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...

    $4,950.00